EANS-Adhoc: - Dr. Dr. h.c. Thomas Middelhoff new chairman of the supervisory board of Marseille-Kliniken AG - Previous chairman Uwe Bergheim stays on as member of the supervisory board, Hans-Hermann Tiedje remains deputy chairman
-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 28.09.2011 Hamburg, 28 September 2011. Uwe Bergheim has resigned as chairman of the supervisory board of Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) on 27 09 2011 due to personal reasons. He stays on as member of the board, likewise as member of the finance and audit committee. The supervisory board of Marseille-Kliniken AG elected from among its members Dr. Dr. h.c. Thomas Middelhoff as new chairman of the supervisory board at yesterday´s meeting. Hans-Hermann Tiedje remains unchanged as deputy chairman of the supervisory board. End of ad hoc release Further inquiry note: Hillermann Consulting Christian Hillermann Investor Relations for Marseille-Kliniken AG Poststraße 14/16 20354 Hamburg Germany Tel.: +49-(0)40 / 320 279-10 Fax: +49-(0)40 / 320 279-114 www.hillermann-consulting.de end of announcement euro adhoc -------------------------------------------------------------------------------- issuer: Marseille-Kliniken AG Alte Jakobstraße 79/80 D-10179 Berlin phone: +49 (0)30 246 32-400 FAX: +49 (0)30 246 32-401 mail: info@marseille-kliniken.de WWW: http://www.marseille-kliniken.de sector: Pharmaceuticals ISIN: DE0007783003 indexes: CDAX, Classic All Share, Prime All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Stuttgart, Düsseldorf, regulated dealing: Hamburg language: English
Original-Content von: Marseille-Kliniken AG, übermittelt durch news aktuell